PUBLISHER: IMARC | PRODUCT CODE: 1518747
PUBLISHER: IMARC | PRODUCT CODE: 1518747
The France diabetes market size reached US$ 1,100.9 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,782.3 Million by 2032, exhibiting a growth rate (CAGR) of 5.33% during 2024-2032.
IMARC's new report "France Diabetes Market Report: 2024-2032" provides an analytical and statistical insight into the France diabetes market. The report provides both current and future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in France. The research study serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the France diabetes market. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the France diabetes market in any form.
Historical, current and future prevalence of diabetes in France
Historical, current and future prevalence of type-1 and type-2 diabetes in France
Historical, current and future prevalence of diabetes in the urban and rural regions in France
Historical, current and future prevalence of diabetes among males and females in France
Historical, current and future prevalence of diabetes among various age groups in France
Historical, current and future diagnosis rates for diabetes in France
Historical, current and future drug treatment rates for diabetes in France
Performance of the Oral Antidiabetics market in France
Performance of key classes
Performance of key players
Market outlook
Performance of the Insulin market in France
Performance of key classes
Performance of key players
Market outlook